Story perspectives

FDA Issues Class II Recalls for Multiple Medications

9/5/2025

50 10

Summary

Story summary

The FDA's recent update details medication recalls and manufacturing violations.
Key recalls include Azelastine, Brimonidine Tartrate/Timolol Maleate, Ketorolac Tromethamine, and Timolol Maleate, all marked as "Class II."
Class II recalls suggest temporary or reversible health risks.
Azelastine's recall affects 105,456 bottles due to sterility concerns, initiated on May 28, 2025.
Consumers can find affected lot numbers and expiration dates in the FDA's Enforcement Report.

1 of 1

Story summary

The FDA's recent update details medication recalls and manufacturing violations.
Key recalls include Azelastine, Brimonidine Tartrate/Timolol Maleate, Ketorolac Tromethamine, and Timolol Maleate, all marked as "Class II."
Class II recalls suggest temporary or reversible health risks.
Azelastine's recall affects 105,456 bottles due to sterility concerns, initiated on May 28, 2025.
Consumers can find affected lot numbers and expiration dates in the FDA's Enforcement Report.